https://www.selleckchem.com/pr....oducts/epz020411.htm
To explore the level of serum interleukin-37 in patients with acute coronary syndrome (ACS) and its prognostic value. Altogether, 121 continuous ACS cases from September 2017 to June 2020 were selected as the research group (RG), and 107 healthy individuals during the same period were obtained as the control group (CG). ELISA was applied to test IL-37 in the serum of the CG and the RG. Chemiluminescence immunoassay was applied to test NT-pro BNP and hs-cTnI in each group and immune scattering turbidimetry to test hs-CRP. The correlati